Literature DB >> 10923628

Exercise diminishes the activity of acetyl-CoA carboxylase in human muscle.

D Dean1, J R Daugaard, M E Young, A Saha, D Vavvas, S Asp, B Kiens, K H Kim, L Witters, E A Richter, N Ruderman.   

Abstract

Studies in rats suggest that increases in fatty acid oxidation in skeletal muscle during exercise are related to the phosphorylation and inhibition of acetyl-CoA carboxylase (ACC), and secondary to this, a decrease in the concentration of malonyl-CoA. Studies in human muscle have not revealed a consistent decrease in the concentration of malonyl-CoA during exercise; however, measurements of ACC activity have not been reported. Thus, whether the same mechanism operates in human muscle in response to physical activity remains uncertain. To investigate this question, ACC was immunoprecipitated from muscle of human volunteers and its activity assayed in the same individual at rest and after one-legged knee-extensor exercise at 60, 85, and 100% of knee extensor VO2max. ACC activity was diminished by 50-75% during exercise with the magnitude of the decrease generally paralleling exercise intensity. Treatment of the immunoprecipitated enzyme with protein phosphatase 2A restored activity to resting values, suggesting the decrease in activity was due to phosphorylation. The measurement of malonyl-CoA in the muscles revealed that its concentration is 1/10 of that in rats, and that it is diminished (12-17%) during the higher-intensity exercises. The respiratory exchange ratio increased with increasing exercise intensity from 0.84 +/- 0.02 at 60% to 0.99 0.04 at 100% VO2max. Calculated rates of whole-body fatty acid oxidation were 121 mg/min at rest and 258 +/- 35, 264 +/- 63, and 174 +/- 76 mg/min at 60, 85, and 100% VO2max, respectively. The results show that ACC activity, and to a lesser extent malonyl-CoA concentration, in human skeletal muscle decrease during exercise. Although these changes may contribute to the increases in fat oxidation from rest to exercise, they do not appear to explain the shift from mixed fuel to predominantly carbohydrate utilization when exercise intensity is increased.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10923628     DOI: 10.2337/diabetes.49.8.1295

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  30 in total

1.  Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle.

Authors:  Blake B Rasmussen; Ulf C Holmbäck; Elena Volpi; Beatrice Morio-Liondore; Douglas Paddon-Jones; Robert R Wolfe
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 2.  Protein acetylation in metabolism - metabolites and cofactors.

Authors:  Keir J Menzies; Hongbo Zhang; Elena Katsyuba; Johan Auwerx
Journal:  Nat Rev Endocrinol       Date:  2015-10-27       Impact factor: 43.330

Review 3.  Regulation and limitations to fatty acid oxidation during exercise.

Authors:  Jacob Jeppesen; Bente Kiens
Journal:  J Physiol       Date:  2012-01-23       Impact factor: 5.182

Review 4.  Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: Thematic Review Series: Genetics of Human Lipid Diseases.

Authors:  Harjot K Saini-Chohan; Ryan W Mitchell; Frédéric M Vaz; Teresa Zelinski; Grant M Hatch
Journal:  J Lipid Res       Date:  2011-11-07       Impact factor: 5.922

Review 5.  New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle.

Authors:  Francis B Stephens; Dumitru Constantin-Teodosiu; Paul L Greenhaff
Journal:  J Physiol       Date:  2007-03-01       Impact factor: 5.182

6.  BRCA1 is a novel regulator of metabolic function in skeletal muscle.

Authors:  Kathryn C Jackson; Eva-Karin Gidlund; Jessica Norrbom; Ana P Valencia; David M Thomson; Rosemary A Schuh; P Darrell Neufer; Espen E Spangenburg
Journal:  J Lipid Res       Date:  2014-02-24       Impact factor: 5.922

7.  Chinese medicine Jinlida (JLD) ameliorates high-fat-diet induced insulin resistance in rats by reducing lipid accumulation in skeletal muscle.

Authors:  Sha-Sha Zang; An Song; Yi-Xuan Liu; Chao Wang; Guang-Yao Song; Xiao-Ling Li; Ya-Jun Zhu; Xian Yu; Ling Li; Chen-Xi Liu; Jun-Cong Kang; Lu-Ping Ren
Journal:  Int J Clin Exp Med       Date:  2015-03-15

8.  Arachidonic acid induces acetyl-CoA carboxylase 1 expression via activation of CREB1.

Authors:  Yin Peng; Ting Lei; Jihong Yuan; Xiaodong Chen; Qinqiang Long; Jian Zhang; Jian Zhan; Peng Lei; Bin Feng; Zaiqing Yang
Journal:  Endocrine       Date:  2009-10-20       Impact factor: 3.633

9.  Novel role of FATP1 in mitochondrial fatty acid oxidation in skeletal muscle cells.

Authors:  David Sebastián; Maria Guitart; Celia García-Martínez; Caroline Mauvezin; Josep M Orellana-Gavaldà; Dolors Serra; Anna M Gómez-Foix; Fausto G Hegardt; Guillermina Asins
Journal:  J Lipid Res       Date:  2009-05-09       Impact factor: 5.922

10.  ACC2 is expressed at high levels in human white adipose and has an isoform with a novel N-terminus [corrected].

Authors:  John C Castle; Yoshikazu Hara; Christopher K Raymond; Philip Garrett-Engele; Kenji Ohwaki; Zhengyan Kan; Jun Kusunoki; Jason M Johnson
Journal:  PLoS One       Date:  2009-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.